1. Home
  2. Browse
  3. Hematology & Oncology

Hematology & Oncology

301 - 315 of 427 Results
Sort Results:
Guideline: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Male Sexual Dysfunction: A Couple's Problem - 2003 Update September 2006
Article: Nexavar (sorafenib), the first ORAL drug for advanced kidney cancer September 2006
Patient Education: Bisphosphonates and Jaw Bone Damage August 2006
Commentary: Bisphosphonates-Associated Jaw Osteonecrosis August 2006
Other: Exemestane (Aromasin) for Early Breast Cancer: New Indication August 2006
Guideline: Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: An advisory statement from theAmerican Dental Association Council on Scientific Affairs (2008) August 2006
Article: Aromasin (exemestane) is now officially approved for POSTmenopausal women with early stage breast cancer August 2006
Other: New Cancer Agent: Sutent (Sunitinib) July 2006
Article: new oral cancer drug in Canada called Sutent July 2006
Other: Safe Handling of Hydrea (Hydoxyurea) Capsules April 2006
Article: wear gloves while handling bottles of hydroxyurea capsules (Hydrea) April 2006
Article: new cancer drugs approved by Health Canada October 2005
Other: New Take-Home Screening Tests for Colon Cancer October 2005
Other: New Cancer Treatments Approved in Canada: Bexxar (Tositumomab), Zevalin (Ibritumomab Tiuxetan), and Avastin October 2005
Article: Tarceva is a new ORAL treatment for lung cancer September 2005